Abstract:Background:Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organs leading to tissue damage1. T lymphocytes have been recognized as key contributors to disease pathogenesis2. Inflammatory Th17 subsets promote inflammation, while defects in regulatory T cells (Tregs) lead to unchecked immune responses3. Emerging data suggest that single miR species can profoundly alter the phenotype and outcome of immune responses in SLE4. Objectives: we describe a role for miR-326 in driving deregulation of Th17/Treg balance in lupus mouse and highlight therapeutic advances of miR-326.Methods:3 groups of female MRL/lpr mice were injected with lentivirus-miR-326 (LV-326) or lentivirus-miR-326 specific inhibitor (LV-sponge) to increase or inhibit miR-326 expression, respectively, and lentivirus-no-encoding (LV-ctrl) as control, 10 mice per group. The percentage of Th17 cells and Tregs in spleen CD4+ T cells and kidney were detected by flow cytometry. The levels of serum cytokine (IL-17A, IFN-γ, TGF-β) were detected by CBA. Urinary collections (24 h) were collected and assessed for albumin using ELISA. Immunohistochemistry labeled kidney IL-17A and TGF-β expression. Differences between groups were analyzed by SPSS software.Results:Day 7 analysis of differentiation of Th17 cells and Tregs in spleen after injection of lentivirus showed an increased percentage of Th17 in LV-326 mice, while reduction of percentage of Tregs in these mice. Testing the serum cytokines revealed that the significantly increased levels of IL-17A and IFN-γ in LV-326 mice, and decreased in LV-sponge mice, no different has been found in TGF-β between the groups. Moreover, LV-326 mice showed higher levels of 24h urinary albumin than LV-sponge and LV-ctrl mice in day 7 after injection of lentivirus. The lentivirus-miR-326 injection promoted the infiltration of Th17 cells and simultaneously increased the expression of IL-17A in kidney, no different has been found of TGF-β.Conclusion:Our data reveal that miR-326 overexpression increased the differentiation of Th17 cells and decreased the differentiation of Tregs, and accelerated the renal injury in MRL/lpr mice. These suggest that miR-326 may play a catalytic role in the development of lupus-like changes in lupus model mouse by breaks Th17/Treg balance.References:[1] Tsokos, G.C. Systemic lupus erythematosus. N Engl J Med365, 2110-2121 (2011). [2] Moulton, V.R. et al. Pathogenesis of Human Systemic Lupus Erythematosus: A [3] Cellular Perspective. Trends Mol Med 23, 615-635 (2017). [4] Suarez-Fueyo, A., Bradley, S.J. & Tsokos, G.C. T cells in Systemic Lupus Erythematosus. Curr Opin Immunol 43, 32-38 (2016). [5] Lam, I.K.Y., Chow, J.X., Lau, C.S. & Chan, V.S.F. MicroRNA-mediated immune regulation in rheumatic diseases. Cancer Lett 431, 201-212 (2018).Disclosure of Interests:None declared

260 MiR-326 promotes renal injury in murine lupus nephritis

261 MiR-326 regulates CD4+T cells differentiation in lupus disease of MRL/lpr mice

MiR-326 overexpression in T cells breaks Th17/Treg balance in MRL/lpr mice

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice

MiR-146a Relieves Kidney Injury in Mice with Systemic Lupus Erythematosus Through Regulating NF-κB Pathway.

Analysis of Microrna-199A-3p Expression in CD4 + T Cells of Systemic Lupus Erythematosus

Expression and Clinical Significan Ce of Mir-326 on Regulatory T Cells of Patients with Systemic Lupus Erythematosus

Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice

MicroRNA-26a: An Emerging Regulator of Renal Biology and Disease.

Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis

177 Decreased expression of renal MiR-127–3p contributes to the overactivation of interferon signaling pathway in the kidney of lupus nephritis

MicroRNA‐130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells

miR‑146a‑5p protects against renal injury in MRL/lpr mice via improvement of the Treg/Th17 imbalance by targeting the TRAF6/NF‑κB axis

Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice

Mir-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (Mif)-Induced Expression of COL1A1

123 Mir-127–3p As a Novel Regulator of Type I Interferon Signalling Pathway in Sle

MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.

MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1

MicroRNA-146A Contributes to Abnormal Activation of the Type I Interferon Pathway in Human Lupus by Targeting the Key Signaling Proteins.

Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2

Elevated Serum Inflammatory Cytokines in Lupus Nephritis Patients, in Association with Promoted Hsa-Mir-125a